Autonomic Effects of Spinal Cord Stimulation in Spinal Cord Injury

September 27, 2024 updated by: Jill M. Wecht, Ed.D., James J. Peters Veterans Affairs Medical Center

Autonomic Effects of Transcutaneous Spinal Cord Stimulation in Veterans With Spinal Cord Injury (SCI)

The goal of this interventional crossover study is to determine the effects of transcutaneous spinal cord stimulation (TSCS) on the ability to perform moderate exercise and regulate core body temperature in the chronic spinal cord injury community. The main questions it aims to answer are:

  • What are the effects of active TSCS targeted for BP control on exercise endurance time and HR recovery during submaximal arm cycle ergometry (ACE) as compared to sham TSCS in participants with chronic, cervical SCI?
  • What are the effects of active TSCS on Tcore responses to cool ambient exposure and on subjective reporting of thermal comfort and thermal sensitivity as compared to sham TSCS.

Participants will receive sham and active stimulation while using an arm bicycle or while in a cold room. Participants are free to participate in either the exercise phase, the cold room phase, or both phases of this study.

Please note that there no expected long term benefits of this study.

Study Overview

Detailed Description

The purpose of the first part of this research study is to determine the effects of active transcutaneous spinal cord stimulation (TSCS) targeted for blood pressure (BP) control on exercise endurance time and heart rate (HR) recovery time during an arm cycle test. The results will help guide experimental studies aimed at improving exercise, rehabilitation, health, and longevity in the SCI population. If the participant chooses to participate in part one of this study, the participant will be asked to visit the laboratory for 2 visits that take about 3-4 hours each.

The purpose of part two of this study is to compare the effects of electricity being delivered through surface electrodes (sticky pads on the participants skin), called active transcutaneous spinal cord stimulation (TSCS), compared to sham TSCS (sticky pads with electricity initially turned on but then turned off) on the participants ability to 1) keep the participants body temperature stable and 2) feel comfortable, while in a cool environment (cool room at 64° F) for 90 minutes. The investigators will assess the participant thermal sensation by asking the participant if overall they feel cold, cool, neutral, warm, or hot and their comfort level by asking the participant to grade their thermal comfort (how comfortable or how uncomfortable they feel) when the participant is seated in a thermoneutral room (80° F) and again in the cool room with active TSCS compared to the cool room with sham TSCS. The results will help guide experimental studies aimed at improving health and longevity in the population with SCI. If the participant chooses to participate in this study, there will be 2 study visits that last about 3-4 hours each.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New York
      • Bronx, New York, United States, 10468
        • Recruiting
        • James J Peters VAMC
        • Principal Investigator:
          • Jill M Wecht, EdD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • You are above the age of 18 years old
  • You have an SCI between C3-T6
  • You have been injured longer than 1 year
  • You participated in a prior experiment "Targeted Transcutaneous Spinal Cord Stimulation to Restore Autonomic Cardiovascular Health in Individuals with Spinal Cord Injury"
  • You have an American Spinal Injury Association injury classification scale (AIS) A, B, C
  • Your prescription medications have not changed for at least 30 days

Exclusion Criteria:

  • You have a history of seizures
  • You have an acute illness or infection
  • You have diabetes
  • You have untreated thyroid disease
  • You have a neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease, etc.)
  • You have a history of heart or vascular disease (coronary artery disease, congestive heart failure, peripheral artery disease,)
  • You have a history of moderate or severe head trauma (TBI) or diagnosed with cognitive impairment
  • You have a present or history of a psychological disorder
  • You have contraindications to electricity over your spine
  • You are dependent on a ventilator to breathe or have an open tracheostomy site
  • You have a recent history of substance abuse (within the past 3 months)
  • You have open wounds over the spine at the level targeted for stimulation
  • You are pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transcutaneous Spinal Cord Stimulation
The transcutaneous spinal cord stimulation used in this experiment is specific to each participant as determined in a previous study. Possible parameters include biphasic or monophasic, Russian or Nonrussian, a variety of pulse widths, and location of stimulation (T7-8, T9-10,- T11-12, L1-2). The amplitude of the stimulation also depends on the results of the mapping study. This stimulation will be delivered 30 minutes at a time.
This is electrical stimulation delivered to the spinal cord through the skin and tissue using a cathode electrode to deliver the stimulation and anode electrodes to ground the circuit.
Other Names:
  • transcutaneous spinal stimulation (TSS)
Sham Comparator: Sham Transcutaneous Spinal Cord Stimulation
The sham stimulation will follow the above parameters but will only be delivered for a minute rather than the full 30 minutes.
This is designed to appear like transcutaneous spinal cord stimulation without actually delivering the stimulation.
Other Names:
  • Sham Transcutaneous Spinal Stimulation
  • Placebo Transcutaneous Spinal Stimulation
  • Placebo Transcutaneous Spinal Cord Stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Endurance Time
Time Frame: During procedures (30 minutes)
Total time (minutes) the participant is able to exercise during the submaximal arm cycle ergometry test.
During procedures (30 minutes)
Recovery Heart Rate
Time Frame: During procedures (60 minutes)
Total time (minutes) for heart rate to return to baseline levels after submaximal exertion.
During procedures (60 minutes)
Tcore
Time Frame: During procedures (90 minutes)
This outcome measure is measured in degrees Celsius.
During procedures (90 minutes)
Thermal Comfort
Time Frame: During procedures (90 minutes)
Feeling of comfort from: +3 (very comfortable) to -3 (very uncomfortable).
During procedures (90 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Workload
Time Frame: End of exercise (30 minutes)
This outcome is measured in Watts (highest watt obtained)
End of exercise (30 minutes)
Rate of Perceived Exhaustion
Time Frame: End of exercise (30 minutes)
This is measured on the Borg scale (06-20) higher number = harder perceived exertion
End of exercise (30 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jill M Wecht, EdD, James J. Peters Veterans Affairs Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2023

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

July 17, 2023

First Submitted That Met QC Criteria

July 17, 2023

First Posted (Actual)

July 25, 2023

Study Record Updates

Last Update Posted (Actual)

October 1, 2024

Last Update Submitted That Met QC Criteria

September 27, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthostatic Hypotension

Clinical Trials on Transcutaneous Spinal Cord Stimulation (TSCS)

Subscribe